Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 693 M770 M4.79 B1.53 B231 M 7.33 B Non-Operating Income, Total -338 M-1.46 B369 M-478 M536 M -1.04 B Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -338 M-1.46 B369 M-478 M536 M -1.04 B Unusual income/expense ————— — Pretax income 934 M652 M2.14 B1.38 B191 M 4.36 B Equity in earnings 67 M217 M-101 M45 M162 M 323 M Taxes 175 M-34 M266 M479 M1.67 B 2.38 B Non-controlling/minority interest 294 M222 M619 M375 M456 M 1.67 B After tax other income/expense ————— — Net income before discontinued operations 465 M464 M1.26 B523 M-1.94 B 308 M Discontinued operations ————— — Net income 465 M464 M1.26 B523 M-1.94 B 308 M Dilution adjustment 00000 0 Preferred dividends 45 M-39 M36 M35 M35 M 67 M Diluted net income available to common stockholders 420 M503 M1.22 B488 M-1.97 B 241 M Basic earnings per share (Basic EPS) ————— — Diluted earnings per share (Diluted EPS) ————— — Average basic shares outstanding ————— — Diluted shares outstanding ————— — EBITDA 1.41 B811 M4.88 B1.66 B246 M 7.6 B EBIT 693 M770 M4.79 B1.53 B231 M 7.33 B Cost of revenue 3.15 B3.13 B3.57 B6.01 B3.97 B 16.68 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 41 M41 M83 M132 M15 M 271 M